Trial intelligence / Profile preview

Dexchlorpheniramine lotion vs cream for sunburn

NCT01085851Phase 3Unknown

Sponsor
Mantecorp Farmasa
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of dexchlorpheniramine in sunburn (2 arms), sponsored by Mantecorp Farmasa. Primary endpoint: Pruritus intensity evaluated with a 10-point Visual Analogic Scale at 7 days. Status: unknown.

02

Drugs

dexchlorpheniramine
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT01085851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01085851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call